Anabolic Steroids Market Trends

  • Report ID: 5986
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Anabolic Steroids Market Trends

Growth Drivers

  • The Prevalence of Hypogonadism in Men is Rising- The growing incidence of hypogonadism in men will drive the anabolic steroids market expansion. It is estimated that between 30 and 50 percent of men with type 2 diabetes or obesity and 35 percent of males over 45 have hypogonadism. A low level of testosterone in males causes hypogonadism, which impairs their quality of life and the function of many organs. The main reasons of male impotence are exhaustion, sleep deprivation, worry, and binge drinking. Breast cancer is the result of women's breast cells developing out of control. These cells develop into a tumor, which appears as an X-ray or can be felt as a bump. The infection of adjacent tissues by these cells leads to malignant malignancy.
  • Infrastructure Spending in the Healthcare Sector is Rising- The increasing cost of healthcare, which contributes to the development of the industry's infrastructure, is another important factor impacting the anabolic steroids market growth rate. Additionally, by boosting funding, a number of government groups hope to strengthen the healthcare infrastructure, which would further alter the dynamics of the market.
  • Growing Popularity Among Youth for Bodybuilding- A primary driver of the anabolic steroid business is the increasing adolescent interest in bodybuilding. The performance-enhancing drug that is used worldwide is called steroids. The rise in athletic events has led to a sharp increase in the demand for steroids, which is good news for the worldwide steroid business. Steroids can promote the growth of facial and pubic hair. It enhances ambition and focus while also deepening the voice. Steroids are therefore advantageous for overly feminine hormones. In the US, an estimated 43% of gym patrons participate in bodybuilding exercises.

Challenges

  • Long-term usage of steroids might have the following side effects- Use of AAS for extended periods of time may harm the immune system. Elevated blood pressure is a typical side effect of AAS, particularly in people who already have hypertension. According to studies, persons who use steroids regularly are more likely to develop cardiovascular diseases. Acne, seborrhea, excessive body hair development, androgenic alopecia, irregular menstruation, and many more are other related side effects. Thus, improper usage of anabolic steroids might have negative consequences on a person and prevent their progress globally.
  • The overuse and abuse of anabolic steroids, particularly in the context of sports and bodybuilding, is one of the main issues facing this anabolic steroids market.  
  • The usage of anabolic steroids can have a number of harmful health repercussions, including heart disease, liver damage, kidney issues, and mental difficulties. This is especially the case when the steroids are taken for extended periods of time or in excess.

Anabolic Steroids Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

9.8%

Base Year Market Size (2024)

USD 16.42 billion

Forecast Year Market Size (2037)

USD 55.36 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5986
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of anabolic steroids is evaluated at USD 17.71 billion.

The anabolic steroids market size was valued at USD 16.42 billion in 2024 and is set to exceed USD 55.36 billion by 2037, registering over 9.8% CAGR during the forecast period i.e., between 2025-2037. Increasing geriatric population and prevalence of hypogonadism in men will drive the market growth.

North America industry is expected to account for largest revenue share of 33% by 2037, impelled by increasing incidence of breast cancer in the region.

The major players in the market include Mylan N.V., F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Johnson & Johnson Private Limited, Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd., Merck & Co., Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample